Cargando…
Fibroblast Growth Factor 9 as a Potential Biomarker for Schizophrenia
Preclinical and clinical studies have suggested that fibroblast growth factor (FGF) system contributed to the onset and development of schizophrenia (SCZ). However, there was no strong clinical evidence to link an individual FGF with SCZ. In this study, we aim to measure blood FGF9 levels in the pat...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082542/ https://www.ncbi.nlm.nih.gov/pubmed/35546939 http://dx.doi.org/10.3389/fpsyt.2022.788677 |